Health ❯ Diseases ❯ Autoimmune Diseases
Symptoms Patient Experiences Personal Experiences Inflammation Genetic Risk Factors Selma Blair Treatment Options Living with MS Living with Multiple Sclerosis Genetic Variants
The program narrows to non‑relapsing secondary progressive MS, with the U.S. decision now expected by the end of the first quarter of 2026.